G. Goodwin, United Kingdom

Guy Goodwin is Emeritus Professor of Psychiatry at the University of Oxford, Oxford, UK. He completed his medical degree and DPhil in Physiology at the University of Oxford and, following training in psychiatry, became a Clinical Scientist and Consultant Psychiatrist at the MRC Brain Metabolism Unit at the Royal Edinburgh Hospital, Edinburgh, UK. Professor Goodwin’s research interests are in the treatment of bipolar disorder and the application of neuroscience in understanding the neurobiology of mood disorders, with a focus on developing new treatments. He has been a lead investigator in clinical trials for mood disorder, and his current interest is the potential to improve treatment using new technology and new drugs, notably the psychedelics. Professor Goodwin has served as a member of the Wellcome Trust Neurosciences Panel, the Council of the British Association for Psychopharmacology, the Clinical Fellowships Panel and Advisory Board of the Medical Research Council. He is a Fellow of the American College of Neuropsychopharmacology and Emeritus Senior Investigator on the faculty of the UK National Institute for Health Research. He has previously held the position of President of the British Association for Psychopharmacology and is a past president of the European College of Neuropsychopharmacology. Professor Goodwin is a Thomson Reuters highly cited researcher (top 1% in field).

Presenter of 2 Presentations

Industry Session not Included in the Main Event CME / CPD Credit (ID 1128) No Topic Needed

Emotional blunting in patients with depression: side effect or symptom?

Session Icon
Pre-Recorded with Live Q&A
Date
Sun, 11.04.2021
Session Time
13:30 - 15:00
Room
Industry 3
Lecture Time
13:50 - 14:05
Industry Session not Included in the Main Event CME / CPD Credit (ID 1128) No Topic Needed

Live Q&A

Session Icon
Pre-Recorded with Live Q&A
Date
Sun, 11.04.2021
Session Time
13:30 - 15:00
Room
Industry 3
Lecture Time
14:30 - 15:00